<DOC>
	<DOCNO>NCT02811224</DOCNO>
	<brief_summary>This prospective , gold standard observational trial design enroll consecutive , consent ovarian cancer patient purpose determine sensitivity assay detects circulate tumor DNA . This observational pilot trial also use examine genetic variants/mutations present tumor tissue DNA .</brief_summary>
	<brief_title>Ovarian Cancer Hemoscope Trial</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Case Group Patients ovarian cancer undergo surgery ( stage ) Over 18 year old Control Group Patients benign gynecological condition undergo surgery Over 18 year old Previous cancer diagnosis ( ) Radiation therapy surgical treatment Bone marrow transplant Chemotherapy surgical treatment Invasive procedure result damage tissue ( e.g. , surgery , biopsy , thermal ablation ) 7 day prior baseline ( presurgical ) blood collection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>